Platinum Salts in Patients with Breast Cancer: A Focus on Predictive Factors

by Mattia Garutti, Giacomo Pelizzari, Michele Bartoletti, Matilde Clarissa Malfatti, Lorenzo Gerratana, Gianluca Tell, Fabio Puglisi
Published 2019-07-01

APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC

by Matilde Clarissa Malfatti, Lorenzo Gerratana, Emiliano Dalla, Miriam Isola, Giuseppe Damante, Carla Di Loreto, Fabio Puglisi, Gianluca Tell
Published 2019-07-01

Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis

by Michele Bartoletti, Giacomo Pelizzari, Lorenzo Gerratana, Lucia Bortot, Davide Lombardi, Milena Nicoloso, Simona Scalone, Giorgio Giorda, Gustavo Baldassarre, Roberto Sorio, Fabio Puglisi
Published 2020-05-01

Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer

by Lorenzo Gerratana, Lorenzo Gerratana, Debora Basile, Debora Basile, Alessandra Franzoni, Lorenzo Allegri, Davide Viotto, Carla Corvaja, Carla Corvaja, Lucia Bortot, Lucia Bortot, Elisa Bertoli, Elisa Bertoli, Silvia Buriolla, Silvia Buriolla, Giada Targato, Giada Targato, Lucia Da Ros, Stefania Russo, Marta Bonotto, Barbara Belletti, Gustavo Baldassarre, Giuseppe Damante, Fabio Puglisi, Fabio Puglisi
Published 2020-09-01

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer

by Andrew A. Davis, Qiang Zhang, Lorenzo Gerratana, Ami N. Shah, Youbin Zhan, Wenan Qiang, Brian S. Finkelman, Lisa Flaum, Amir Behdad, William J. Gradishar, Leonidas C. Platanias, Massimo Cristofanilli
Published 2019-12-01

Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside

by Debora Basile, Paola Di Nardo, Carla Corvaja, Silvio Ken Garattini, Giacomo Pelizzari, Camilla Lisanti, Lucia Bortot, Lucia Da Ros, Michele Bartoletti, Matteo Borghi, Lorenzo Gerratana, Davide Lombardi, Fabio Puglisi
Published 2019-06-01

Landscape of circulating tumour DNA in metastatic breast cancer

by Andrew A. Davis, Saya Jacob, Lorenzo Gerratana, Ami N. Shah, Firas Wehbe, Neelima Katam, Qiang Zhang, Lisa Flaum, Kalliopi P. Siziopikou, Leonidas C. Platanias, William J. Gradishar, Amir Behdad, Massimo Cristofanilli
Published 2020-08-01

KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC

by Marika Cinausero, Noemi Laprovitera, Giovanna De Maglio, Lorenzo Gerratana, Mattia Riefolo, Marianna Macerelli, Michelangelo Fiorentino, Elisa Porcellini, Vanessa Buoro, Francesco Gelsomino, Anna Squadrilli, Gianpiero Fasola, Massimo Negrini, Marcello Tiseo, Manuela Ferracin, Andrea Ardizzoni
Published 2019-11-01

Role of Bruton’s Tyrosine Kinase in Stage III Colorectal Cancer

by Debora Basile, Lorenzo Gerratana, Angela Buonadonna, Silvio Ken Garattini, Tiziana Perin, Emanuela Grassilli, Gianmaria Miolo, Maria Grazia Cerrito, Claudio Belluco, Giulio Bertola, Antonino De Paoli, Renato Cannizzaro, Marialuisa Lavitrano, Fabio Puglisi, Vincenzo Canzonieri
Published 2019-06-01

Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC)

by Yulan Gong, Rajeswari Nagarathinam, Maria F. Arisi, Lorenzo Gerratana, Jennifer S. Winn, Michael Slifker, Jianming Pei, Kathy Q. Cai, Zachary Hasse, Elias Obeid, Julio Noriega, Christopher Sebastiano, Eric Ross, Katherine Alpaugh, Massimo Cristofanilli, Sandra V. Fernandez
Published 2021-08-01

Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer

by Carolina Reduzzi, Serena Di Cosimo, Lorenzo Gerratana, Rosita Motta, Antonia Martinetti, Andrea Vingiani, Paolo D’Amico, Youbin Zhang, Marta Vismara, Catherine Depretto, Gianfranco Scaperrotta, Secondo Folli, Giancarlo Pruneri, Massimo Cristofanilli, Maria Grazia Daidone, Vera Cappelletti
Published 2021-05-01

Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for a Cost-Effective and Dynamic Biomarker

by Giacomo Pelizzari, Debora Basile, Silvia Zago, Camilla Lisanti, Michele Bartoletti, Lucia Bortot, Maria Grazia Vitale, Valentina Fanotto, Serena Barban, Marika Cinausero, Marta Bonotto, Lorenzo Gerratana, Mauro Mansutti, Francesco Curcio, Gianpiero Fasola, Alessandro Marco Minisini, Fabio Puglisi
Published 2019-08-01

First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study

by Debora Basile, Lorenzo Gerratana, Carla Corvaja, Giacomo Pelizzari, Giorgia Franceschin, Elisa Bertoli, Lorenza Palmero, Diego Zara, Martina Alberti, Silvia Buriolla, Lucia Da Ros, Marta Bonotto, Mauro Mansutti, Simon Spazzapan, Marika Cinausero, Alessandro Marco Minisini, Gianpiero Fasola, Fabio Puglisi
Published 2021-06-01

Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer

by Fabio Puglisi, Lorenzo Gerratana, Matteo Lambertini, Marcello Ceppi, Luca Boni, Filippo Montemurro, Stefania Russo, Claudia Bighin, Michelino De Laurentiis, Mario Giuliano, Giancarlo Bisagni, Antonio Durando, Anna Turletti, Ornella Garrone, Andrea Ardizzoni, Teresa Gamucci, Giuseppe Colantuoni, Adriano Gravina, Sabino De Placido, Francesco Cognetti, Lucia Del Mastro
Published 2021-06-01

The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients

by Debora Basile, Annamaria Parnofiello, Maria Grazia Vitale, Francesco Cortiula, Lorenzo Gerratana, Valentina Fanotto, Camilla Lisanti, Giacomo Pelizzari, Elena Ongaro, Michele Bartoletti, Silvio Ken Garattini, Victoria Josephine Andreotti, Anna Bacco, Donatella Iacono, Marta Bonotto, Mariaelena Casagrande, Paola Ermacora, Fabio Puglisi, Nicoletta Pella, Gianpiero Fasola, Giuseppe Aprile, Giovanni G. Cardellino
Published 2019-04-01